Literature DB >> 23803239

Percutaneous ventricular assist device and extracorporeal membrane oxygenation support in a patient with postinfarction ventricular septal defect and free wall rupture.

Igor D Gregoric1, Tomaz Mesar, Biswajit Kar, Sriram Nathan, Rajko Radovancevic, Manish Patel, Pranav Loyalka.   

Abstract

We describe the case of a 54-year-old woman with a postinfarction ventricular septal defect (VSD) and ventricular free wall rupture who was stabilized with a percutaneous ventricular assist device (pVAD) to allow for myocardial infarct stabilization. Following the rupture of the right ventricular free wall and cardiopulmonary arrest on hospital day 10, pVAD support was promptly converted to extracorporeal membrane oxygenation (ECMO) support for stabilization. After surgical repair was completed, pVAD support was continued for 4 days to allow recovery. The patient was discharged on postoperative day 11 and is alive and well 4 years later. Postinfarction VSD with free wall rupture may be salvaged with pVAD and ECMO support.

Entities:  

Mesh:

Year:  2013        PMID: 23803239     DOI: 10.1532/HSF98.20121123

Source DB:  PubMed          Journal:  Heart Surg Forum        ISSN: 1098-3511            Impact factor:   0.676


  3 in total

Review 1.  Pre- and post-operative mechanical circulatory support in surgical repair of post-acute myocardial infarction mechanical complications.

Authors:  Anju Bhardwaj; Sachin Kumar; Ismael A Salas de Armas; Angelo Nascimbene; Sriram Nathan; Biswajit Kar; Igor D Gregoric
Journal:  Ann Cardiothorac Surg       Date:  2022-05

2.  Using extracorporeal membrane oxygenation support preoperatively and postoperatively as a successful bridge to recovery in a patient with a large infarct-induced ventricular septal defect.

Authors:  Samuel Jacob; Mitesh J Patel; Brian Lima; Joost Felius; Rajasekhar S Malyala; Themistokles Chamogeorgakis; Juan C MacHannaford; Gonzalo V Gonzalez-Stawinski; Aldo E Rafael
Journal:  Proc (Bayl Univ Med Cent)       Date:  2016-07

Review 3.  Reperfusion therapy reduces the risk of myocardial rupture complicating ST-elevation myocardial infarction.

Authors:  Eric R Bates
Journal:  J Am Heart Assoc       Date:  2014-10-20       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.